Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14276 - 14300 of 14425 in total
R-95845 is an inhibitor of HIV-1 reverse transcriptase.
Experimental
Investigational
BMS-488043 has been investigated as an anti-HIV agent.
Investigational
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
BMS-394136 has been used in trials studying the diagnostic of Heart Diseases.
Investigational
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and
Displaying drugs 14276 - 14300 of 14425 in total